Diagnostic anti-[Hepatitis b virus (HBV)] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays

Cat No.: GMP-HBV-1Ab

Hepatitis B is a vaccine-preventable liver infection caused by the hepatitis B virus (HBV). Hepatitis B is spread when blood, semen, or other body fluids from a person infected with the virus enters the body of someone who is not infected. This can happen through sexual contact; sharing needles, syringes, or other drug-injection equipment; or from mother to baby at birth. Not all people newly infected with HBV have symptoms, but for those that do, symptoms can include fatigue, poor appetite, stomach pain, nausea, and jaundice. For many people, hepatitis B is a short-term illness. For others, it can become a long-term, chronic infection that can lead to serious, even life-threatening health issues like cirrhosis or liver cancer. Risk for chronic infection is related to age at infection: about 90% of infants with hepatitis B go on to develop chronic infection, whereas only 2%-6% of people who get hepatitis B as adults become chronically infected. The best way to prevent hepatitis B is to get vaccinated.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-Hepatitis b virus (HBV) monoclonal antibody for rapid test kit of Hepatitis b virus (HBV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-HBV-1Ab-1mg 1mg 1953
GMP-HBV-1Ab-10mg 10mg 13671
GMP-HBV-1Ab-100mg 100mg 95697
GMP-HBV-1Ab-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Antigen & Antibody Name Mouse anti-Hepatitis b virus (HBV) monoclonal antibody
Expression platform CHO
IsotypesMouse IgG
Bioactivity validationAntibody Binding, Immunogen in Sandwich Elisa,lateral-flow tests, and other immunoassays in[Hepatitis b virus (HBV)] level test in human infectious disease diagnositcs.
TagmFc
Products descriptionHepatitis B is a vaccine-preventable liver infection caused by the hepatitis B virus (HBV). Hepatitis B is spread when blood, semen, or other body fluids from a person infected with the virus enters the body of someone who is not infected. This can happen through sexual contact; sharing needles, syringes, or other drug-injection equipment; or from mother to baby at birth. Not all people newly infected with HBV have symptoms, but for those that do, symptoms can include fatigue, poor appetite, stomach pain, nausea, and jaundice. For many people, hepatitis B is a short-term illness. For others, it can become a long-term, chronic infection that can lead to serious, even life-threatening health issues like cirrhosis or liver cancer. Risk for chronic infection is related to age at infection: about 90% of infants with hepatitis B go on to develop chronic infection, whereas only 2%-6% of people who get hepatitis B as adults become chronically infected. The best way to prevent hepatitis B is to get vaccinated.
PurityPurity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & ReconstitutionLyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.